DJIA 16,408.54 -16.31 -0.10%
NASDAQ 4,095.52 0.00 0.00%
S&P 500 1,864.85 2.54 0.14%
market minute promo

Amarin Corp plc (ADR)

NASDAQ: AMRN

1.58 -0.02 (-1.25%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AMRN $1.58 -1.25%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.60
Previous Close $1.60
Daily Range $1.55 - $1.65
52-Week Range $1.36 - $7.98
Market Cap $272.5M
P/E Ratio -1.23
Dividend (Yield) $0.00 (0.0%)
Volume 937,324
Average Daily Volume 2,381,203
Current FY EPS -$0.63

Sector

Healthcare

Industry

Drugs

Amarin Corp plc (ADR) (AMRN) Description

The Company is engaged in the research, development and commercialization of novel drugs for the treatment of central nervous system disorders. Website: http://www.amarincorp.com/

News & Commentary

Two Years Less Exclusivity Is the Least of Amarin's Issues

Amarin's patents holding up in court and being able to compete with GlaxoSmithKline's Lovaza for patients are much bigger deals.

Amarin Takes Step 1, Of A Million, To Right Its Ship

Sector Update: Healthcare Shares Flat in Pre-Market Trade; Amarin Partners with Kowa to Promote Vasc

Sector Update: Healthcare Shares Flat in Pre-Market Trade; Amarin Partners with Kowa to Promote Vascepa

Sector Update: Healthcares

Amarin: How The Co-Promotion Agreement With Kowa Affects Required Sales Targets

3 Biotech Stocks Under $10 to Trade for Breakouts

Looking For Value Among Biotechs After Precipitous Declines In Stock Price

Biotech Stock Mailbag: Amarin, Cytrx, Sangamo and 'Story Stocks'

Are Biotech Stocks Located in Ireland Top Buyout Candidates?

5 Stocks Under $10 Set to Soar

Amarin Management Discusses Q4 2013 Results - Earnings Call Transcript

See More AMRN News...

AMRN's Top Competitors

AMRN $1.58 (-1.25%)
Current stock: AMRN
JNJ $98.96 (0.21%)
Current stock: JNJ
NVS $84.67 (0.31%)
Current stock: NVS
RHHBY $36.22 (0.14%)
Current stock: RHHBY